H. Prisack

发表

Novel lipophilic chloroquine analogues for a highly efficient gene transfer into gynecological tumors.

P. Dall, H. Bojar, O. Keil, 2001, Bioorganic & medicinal chemistry letters.

Local inflammation and devascularization — in vivo mechanisms of the “bystander effect” in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma

F. Floeth, H. Bojar, H. Prisack, 2001, Cancer Gene Therapy.

Analysis of BRCA1, TP53, and TSG101 germline mutations in German breast and/or ovarian cancer families.

H. Bojar, H. Prisack, V. Balz, 2002, Cancer genetics and cytogenetics.

Identifying Superficial, Muscle-Invasive, and Metastasizing Transitional Cell Carcinoma of the Bladder

Rolf Ackermann, H. Bojar, M. Grimm, 2004, Clinical Cancer Research.

Gene expression profiling of advanced head and neck squamous cell carcinomas and two squamous cell carcinoma cell lines under radio/chemotherapy using cDNA arrays.

H. Bojar, H. Prisack, O. Modlich, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Breast cancer expression profiling: the impact of microarray testing on clinical decision making

H. Bojar, H. Prisack, O. Modlich, 2006, Expert opinion on pharmacotherapy.

Predictive biological markers for response of invasive breast cancer to anthracycline/cyclophosphamide-based primary (radio-)chemotherapy.

H. Bojar, H. Prisack, O. Modlich, 2005, Anticancer research.

Novel cGMP liposomal vectors mediate efficient gene transfer

A. Hemminki, G. Bauerschmitz, P. Dall, 2003, Cancer Gene Therapy.

Predictors of primary breast cancers responsiveness to preoperative Epirubicin/Cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures

H. Bojar, H. Prisack, O. Modlich, 2005, Journal of Translational Medicine.

Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector

H. Bojar, F. Heyd, U. Steidl, 2003, Cancer Gene Therapy.

Immediate Gene Expression Changes After the First Course of Neoadjuvant Chemotherapy in Patients with Primary Breast Cancer Disease

H. Bojar, H. Prisack, O. Modlich, 2004, Clinical Cancer Research.

Tumor-infiltrating lymphocytes mediate complete and durable remission in a patient with NY-ESO-1 expressing prostate cancer

J. Karbach, H. Prisack, E. Jäger, 2023, Journal for ImmunoTherapy of Cancer.

Gene expression profiles in the acutely dissected human aorta.

H. Bojar, H. Bojar, H. Prisack, 2002, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease

H. Bojar, C. Matuschek, H. Prisack, 2010, European journal of medical research.